These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 5804545)

  • 1. [Clinical and experimental studies of liver damages in tuberculosis, with special reference to liver damages caused by antitubercular agents and the autonomic nervous factor].
    Homma Y
    Iryo; 1969 Apr; 23(4):482-501. PubMed ID: 5804545
    [No Abstract]   [Full Text] [Related]  

  • 2. [S-adenosylmethionine in the therapy of liver insufficiency during a course of pulmonary tuberculosis].
    Durigato S
    Minerva Med; 1972 Dec; 63(91):5024-9. PubMed ID: 4566543
    [No Abstract]   [Full Text] [Related]  

  • 3. [Liver damage caused by the continued use of chemotherapy of pulmonary tuberculosis].
    Yamazaki M; Endo K; Noguchi T; Nakano M
    Iryo; 1966 Apr; 20(4):347-53. PubMed ID: 5974193
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tuberculosis and live with special reference to lesions due to antimycobacterial agents].
    Daddi G; Boccitto G; Storniello G; Salvati F
    Epatologia; 1970; 16(1):71-6. PubMed ID: 5525569
    [No Abstract]   [Full Text] [Related]  

  • 5. Liver function testing in African patients on treatment for tuberculosis.
    Davies PD
    East Afr Med J; 1985 Jul; 62(7):486-90. PubMed ID: 4076028
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the hepatotoxic effect of antituberculous drugs in tuberculosis patients abusing alcohol.
    Grymiński J; Lyczewska J; Styszewska H; Walczak J
    Pol Med J; 1970; 9(3):635-44. PubMed ID: 5452841
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk factors for drug induced hepatitis with first-line antituberculosis drugs in hospitalized patients of pulmonary tuberculosis.
    Pore SM; Shinde K
    J Postgrad Med; 2014; 60(1):90-2. PubMed ID: 24625953
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ultrasonic examination of the liver in patients with pulmonary tuberculosis].
    Ivanov AK; Dzodzuashvili KA
    Klin Med (Mosk); 1990 Jan; 68(1):100-3. PubMed ID: 2186199
    [No Abstract]   [Full Text] [Related]  

  • 9. [Liver changes during treatment with antitubercular agents].
    Velojic D; Jankovic Z; MArsenic B
    Plucne Bolesti Tuberk; 1975; 27(1-2):53-60. PubMed ID: 1161927
    [No Abstract]   [Full Text] [Related]  

  • 10. [Protective effect of silibinin on liver injury induced by antituberculosis drugs].
    Li J; Lin WF; Pan YY; Zhu XY
    Zhonghua Gan Zang Bing Za Zhi; 2010 May; 18(5):385-6. PubMed ID: 20510009
    [No Abstract]   [Full Text] [Related]  

  • 11. [Value of some liver function tests routinely performed in early detection of damage to liver parenchyma in patients with pulmonary tuberculosis].
    Pruszyńska S
    Gruzlica; 1971 Dec; 39(12):1205-9. PubMed ID: 5139239
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemotherapy of pulmonary tuberculosis with liver damage].
    Overrath H
    Prax Pneumol; 1973 Mar; 27(3):182-90. PubMed ID: 4699468
    [No Abstract]   [Full Text] [Related]  

  • 13. [The impact of antituberculosis drugs upon liver function in patients with positive HBVM].
    Chen GQ
    Zhonghua Jie He He Hu Xi Za Zhi; 1989 Apr; 12(2):89-90, 126. PubMed ID: 2791129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver function tests during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin & pyrazinamide.
    Swamy R; Acharyulu GS; Duraipandian M; Jawahar MS; Ramachandran R; Sarma GR
    Indian J Med Res; 1987 Nov; 86():549-57. PubMed ID: 3451899
    [No Abstract]   [Full Text] [Related]  

  • 15. Liver function disorders in the course of continuous and intermittent treatment of patients with chronic pulmonary tuberculosis.
    Kucharska A
    Gruzlica; 1975 Dec; 43(12):1099-106. PubMed ID: 1193414
    [No Abstract]   [Full Text] [Related]  

  • 16. [Morphologic and functional picture of the liver in recent pulmonary tuberculosis and its evolution after chemoantibiotic therapy].
    Greco S; Dusi U; Menozzi V
    Riv Anat Patol Oncol; 1964 Jun; 25(6):Suppl:431-52. PubMed ID: 5827720
    [No Abstract]   [Full Text] [Related]  

  • 17. Side effects and toxicity of ethionamide and prothionamide.
    Tala E; Tevola K
    Ann Clin Res; 1969 May; 1(1):32-5. PubMed ID: 5350768
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hepatic function monitoring during tuberculotherapy (author's transl)].
    Pageaux JF; Duperray B; Dubois M; Pacheco H; Pacheco Y; Brun J; Perrin-Fayolle M; Kofman J
    Therapie; 1979; 34(4):505-13. PubMed ID: 531782
    [No Abstract]   [Full Text] [Related]  

  • 19. [Radioisotope study of liver function in drug-induced toxico-allergic reactions in patients with ruberculosis].
    Vil'derman AM; Frenkel' VKh; Reznik SE; Tikhun MN
    Med Radiol (Mosk); 1967 Apr; 12(4):62-6. PubMed ID: 6052187
    [No Abstract]   [Full Text] [Related]  

  • 20. [Functional state of the liver in patients with pulmonary tuberculosis against a background of antibacterial therapy].
    Latyshev NN
    Probl Tuberk; 1967; 45(9):54-8. PubMed ID: 5606480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.